In addition to Abbott and Thermo, consider the other players who have the same test already approved for use by the FDA:
- BD Veritor CoV-2 & Flu A & B
- Applied Biosystem TaqPath Combo COVID-19, FluA, FluB
- Lucira COVID - Influenza A & B
- Quidel Sophia 2 Flu+SARS
- Roche Liat SARA-Cov-2 + Influenza A/B Multiplex
LUMOS isn't even at the starting line for Virdex revenue and all of the other racers packed up, went home, and are looking for the next run.
I am beginning to think the change in leadership here was a bad move. I was hoping for a fresh outlook and strategic moves.
Where the previous admin "failed fast" and moved on, this leadership seems to fail hard and not admit it to themselves. Dragging investors down while saying "everything is fine".
In addition to Abbott and Thermo, consider the other players who...
Add LDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
-0.004(8.70%) |
Mkt cap ! $21.17M | |||
| Open | High | Low | Value | Volume |
| 4.6¢ | 4.6¢ | 4.2¢ | $230.1K | 5.259M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 534989 | 4.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 221428 | 2 |
View Market Depth
| Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
| LDX (ASX) Chart |